
Sign up to save your podcasts
Or


Interview with Benjamin Besse, MD, author of Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
By JAMA Network3.8
1111 ratings
Interview with Benjamin Besse, MD, author of Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

321 Listeners

504 Listeners

39 Listeners

163 Listeners

59 Listeners

113,121 Listeners

38 Listeners

56,944 Listeners

21 Listeners

16 Listeners

8 Listeners

17 Listeners

19 Listeners

5 Listeners

6 Listeners

46 Listeners

31 Listeners

9 Listeners

94 Listeners

14 Listeners

5 Listeners

5 Listeners

106 Listeners

18 Listeners

15,506 Listeners

2 Listeners

1,209 Listeners